Delhi Neurological Association

Details

Name :

Delhi Neurological Association

Address  :

79 Kiran Vihar,
Department of Neurosurgery

Town  :

New Delhi

State  :

Delhi

Country  :

INDIA

Post Code:

110092

Phone  :

+91- 9810661522 , +(91) - 7840020522

Web URL  :

Delhi Neurological Association
Specialization
  • Neuro Surgeon
  • Neurologist
Facilities

Speciality Type :

Super Speciality :

Other Facilities

  • CT/MRI

Description

DNA Delhi Neurological Association is scientific body of full time practicing doctors of any branch of Neurological Sciences and or possessing a post graduate degree or diploma in any sub specialty of Neurological Sciences like a Neurology Neurosurgery Neuropathology Neuroradiology Neuroanesthesia Neurophysiology and Neuroanatomy

The aims and objectives for which the association is set up are

To maintain close association and cooperation among those devoting full time to any branch of neurological sciences within and outside India

To maintain the highest standard in the ethics and practice in all the fields of Neurological Sciences

To maintain the high standard every endeavor shall be made to provide updating knowledge through scientific programsmeetings etc to those who are properly qualified

To promote and encourage research in all the fields of neurological sciences

To receive and accept donations gifts grants or contributions in kind and cash frome any person or persons associations societies companies authority or Government for the furtherance of the aims and objectives of the Association

Narayana Hrudayalaya to set up Rs 150 cr hospital in Assam

Bangalorebased Narayana Hrudayalaya Hospitals Pvt Ltd NHHPL will be soon partnering the Assam government to set up a Rs 150 crore superspeciality hospital in Amingoan near Guwahati The Assam government on Tuesday signed a memorandum of understanding MoU with NHHPL to set up the project under publicprivatepartnership mode PPP mode It will be a 30... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More